Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data

Like
1
Favorite

Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data

seekingalpha2022-07-06

selvanegra/iStock via Getty Images Shares of Applied Molecular Transport (NASDAQ:AMTI) are up ~4% in after-hours trading after the company said it will release top-line results from a phase 2 trial ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

DuckF4rt
·2022-07-06
Do you think this will rally the stock price?
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2249687531?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-07-06 04:37","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2249687531","market":"us","top_or_hot":-1,"title":"Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data","media":"seekingalpha","content":"<div>\n<p>selvanegra/iStock via Getty Images \n\nShares of Applied Molecular Transport (NASDAQ:AMTI) are up ~4% in after-hours trading after the company said it will release top-line results from a phase 2 trial ...</p>\n\n<a href=\"https://seekingalpha.com/news/3854404-applied-molecular-transport-up-4-after-hours-on-ulcerative-colitis-candidate-data\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApplied Molecular Transport up 4% after hours on ulcerative colitis candidate data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-06 04:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3854404-applied-molecular-transport-up-4-after-hours-on-ulcerative-colitis-candidate-data><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>selvanegra/iStock via Getty Images \n\nShares of Applied Molecular Transport (NASDAQ:AMTI) are up ~4% in after-hours trading after the company said it will release top-line results from a phase 2 trial ...</p>\n\n<a href=\"https://seekingalpha.com/news/3854404-applied-molecular-transport-up-4-after-hours-on-ulcerative-colitis-candidate-data\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/3854404-applied-molecular-transport-up-4-after-hours-on-ulcerative-colitis-candidate-data","article_id":"2249687531","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2249687531","pubTimestamp":1657053436,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"selvanegra/iStock via Getty Images \n\nShares of Applied Molecular Transport (NASDAQ:AMTI) are up ~4% ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","AMTI":"Applied Molecular Transport Inc."},"translate_title":"应用分子转运在溃疡性结肠炎候选数据上几小时后提高了4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMTI":1},"content_text":"selvanegra/iStock via Getty Images \n\nShares of Applied Molecular Transport (NASDAQ:AMTI) are up ~4% in after-hours trading after the company said it will release top-line results from a phase 2 trial of AMT-101 for ulcerative colitis before Wednesday's opening bell.\nThe trial enrolled biologic-naive patients with moderate-to-severe disease. AMT-101 was given with a TNFα inhibitor.\nAMT-101 is a GI-selective, oral recombinant biologic fusion protein of human interleukin 10 (hIL-10).\nIn May, Applied Molecular implemented a cost and workforce cutting plan.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9070730504,"gmtCreate":1657103773508,"gmtModify":1676535949799,"author":{"id":"4090406925906500","authorId":"4090406925906500","name":"DuckF4rt","avatar":"https://static.tigerbbs.com/8d0d4071e18aa22c445faee0a8a457e0","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"4090406925906500","authorIdStr":"4090406925906500"},"htmlText":"Do you think this will rally the stock price?","listText":"Do you think this will rally the stock price?","text":"Do you think this will rally the stock price?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9070730504","repostId":2249687531,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}